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Reliability of Theophylline Clearance in
Determining Maintenance Intravenous
Aminophylline Therapy
Geoffrey R. Grambau, MD, Gary E. Johnson, PharmD, Paul F. Gonlon, PharmD,
and John G. Weg, MD
A lthough theophylline has long been the primary
drug used for the management of reversible
obstructive airway disease, current recommendations
for determining theophylline dosage have not been
dependable and, when applied to individual patients,
have resulted in a wide range of serum theophylline
concentrations (STC) and frequent adverse reac-
tions.1-3
The objective of this study was to evaluate the
clinical reliability of using theophylline clearance
values to adjust the theophylline infusion rate to
achieve a desired STC and to determine the minimum
time required for administration of a continuous
theophylline infusion in a given population of
patients before obtaining a single STC for the clinical-
ly reliable calculation of theophylline clearance.
METHODS
Twelve patients admitted to The University of Mich-
igan Hospitals with disease manifesting reversible
obstructive airway disease requiring intravenous the-
ophylline therapy were subjects in this study. Patients
with liver disease (serum bilirubin > 3.0 mg/dL or
SGOT> 100 U/mL), renal insufficiency (serum creat-
inine > 2.0 mg/dL), congestive heart failure, or pul-
monary edema or who received interfering drugs
within 72 hours of admission were excluded. Patients
who had received regular or sustained-release oral
theophylline preparations in the previous six or 12
hours, respectively, were also excluded. The age of
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the patients ranged from 19 to 64 years and four were
cigarette smokers. Informed consent was obtained
from each patient, and the study protocol was
approved by the Human Use Committee of the Uni-
versity of Michigan Medical School.
Each patient received theophylline (aminophylline
USP, Searle Lot 3-714) by constant intravenous infu-
sion with an IVAC-500 constant infusion pump. Med-
ication records were reviewed to insure that the
infusion was maintained at a constant rate. If patients
were receiving other medications, these were kept
constant during the study period. In each case, the
initial infusion rate and loading dose of theophylline
were determined by the primary physician, who was
not required to follow the investigator’s recommenda-
tions. Blood samples for determination of the STC
were obtained by venipuncture at 6, 12, and 24 hours
(STC-6, STC-12, STC-24) after the initiation of the
continuous theophylline infusion. The STC obtained
at 24 hours represented 83.5% to 93.75% of the
steady-state STC in the nonsmoking patients and
93.75% to 100% of the steady-state STC in the patients
who were smokers.4 The STC obtained at 24 hours
was used to calculate the patient’s theophylline clear-
ance as follows:
Cl- Ro X c
Cs8
[1]
where Cl = theophylline clearance (L/kglhr);
Ro = aminophylline infusion rate (mg/kg/hr);
c = conversion factor: aminophylline contains ap-
proximately 80% anhydrous theophylline5; and
Cs8 = steady-state STC in sg/mL.
Based on the patient’s calculated theophylline
clearance, a new maintenance theophylline infusion
rate (R1) was calculated to produce a change, as
desired by the primary physician, using the following
rearrangement of equation 1:
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TABLE I
Demographic Data on 12 Study Patients
AgeWeight Cigarette Loading Dose5
Maintenance Infusion Rate
Initialt Adjusted4
Patient Sex (yrs) (kg) Smoker (mg) (mg/hr) (mg/hr)
1 F 22 35 No 200 33 38
2 M 29 73 Yes 420 70 107
3 M 63 100 Yes 400 67 50
4 F 64 73 No None 50 33
5 M 19 75 No 400 33 21
6 F 55 51 No 300 50 67
7 F 54 53 Yes 400 67 83
8 F 23 59 No 300 50 58
9 M 61 65 No 250 42 63
10 M 58 88 No 300 50 73
11 M 60 56 Yes 100 17 42
12 M 53 81 No None 50 75
*Loading dose of aminophylline.
tlnitial aminophylline infusion rate.
tAdjusted aminophylline infusion rate based on the serum theophylline concentration measured at 24 hours.
This patient by history was very sensitive to theophylline and therefore the initial dose was lowered.
M = male; F = female.
Cl X Cs8 desired
R1= c
The new infusion rate was immediately started, and
the STC was measured 24 hours later (STC-48).
Each patient’s theophylline clearance was also cal-
culated based on the STC-6 and STC-12, and the STC
resulting from change in the theophylline infusion
rate was estimated using a rearrangement of equation
1. The STC-48 and the estimated STC, based on the
patient’s calculated theophylline clearance using
STC-6, STC-12, and STC-24, were analyzed using
least-squares linear regression. The total time from
initiation of the loading dose to the final STC-48 was
between 48 and 60 hours for all patients in the
study.
All STCs were determined by high-pressure cation-
exchange chromatography according to a modifica-
tion of the method of Weinberger and Chidsay.6 The
95% confidence limits of this method are ± 1.0 sg/mL
for STC between 10 and 20 ig/mL.
RESULTS
Twelve adult patients were subjects in this study
(Table I). The STC measured at 6, 12, and 24 hours
after the initial theophylline infusion rate was started
and the respective calculated theophylline clearance
are presented in Table II. The estimated and mea-
[2] sured STC-48 are also presented in Table II. The
equations and correlation coefficients for the least-
squares linear regression line for the measured STC-
48 versus the estimated STC-48 based on the theo-
phylline clearance calculated using the STC-6, STC-
12, and STC-24 are as follows: y = 13.91 - 0.000lx,
r = -.0003; y = 0.75x + 2.58, r = .81; and y = 0.92x
+ 0.98, r = .99, respectively.
DISCUSSION
Theophylline clearance varies significantly between
patients; this was also demonstrated in this study
(Table II). For this reason, theophylline therapy must
be individualized to maximize the therapeutic effect
and to prevent toxicity. This study evaluated a reli-
able and clinically useful method to do this. Once
80% of steady state is achieved, theophylline clear-
ance based on a single STC and a desired change in
STC may be reliably calculated using equations 1 and
2, which can be combined to give:
Ro - R1
Cs8 (measured) - Cs8 (desired)
[3]
The desired Cs8 is chosen and R1 is determined.
Although the accuracy of equation 3 improves as
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(L/kg/hr)Patient 6 hr 12 hr 24 hr 6 hr 12 hr 24 hr 6 hr 12 hr 24 hr
1 10.8 13.7 17.5 0.069 0.054 0.043 12.4 15.8 20.1 20.6 0.042
2 9.7 6.8 7.1 0.078 0.111 0.107 14.8 10.4 10.8 10.8 0.107
3 19.2 23.5 20.9 0.028 0.022 0.025 14.3 17.5 15.6 16.1 0.024
4 18.6 21.0 20.1 0.029 0.026 0.027 12.3 13.7 13.3 14.0 0.026
5 23.6 21.3 27.8 0.015 0.016 0.013 15.0 13.6 17.7 18.0 0.012
6 9.4 9.7 10.3 0.082 0.080 0.075 12.6 13.0 13.8 14.2 0.073
7 13.4 13.5 12.3 0.075 0.074 0.081 16.6 16.7 15.2 15.9 0.078
8 NA 6.4 7.4 NA 0.105 0.090 NA 7.4 8.6 8.1 0.096
9 8.8 9.4 6.8 0.058 0.054 0.075 13.2 14.1 10.2 10.2 0.075
10 NA 8.9 9.5 NA 0.050 0.047 NA 13.0 13.9 13.2 0.050
11 NA 2.4 3.1 NA 0.010 0.077 NA 5.9 7.7 7.8 0.076
12 NA 5.9 7.5 NA 0.083 0.065 NA 8.8 11.2 10.3 0.071
Measured after initial aminophylline infusion rate was started.
tCalculated from the STC obtained at 6, 12. and 24 hours.
tEstimated for the adjusted aminophylline infusion rate and the calculated theophylline clearance based on the STC measured at 6, 12, and 24 hours.
§Measured 24 hours after the initiation of the adjusted aminophylline infusion rate (STC-48).
ilCalculated from the STC measured 24 hours after the initiation of the adjusted aminophylline infusion rate.
STC = serum theophylline concentration; NA = not available.
the STC approaches steady state, the ability to make
theophylline dosage adjustments prior to steady state
being achieved is of great clinical importance.
All patients in this study were successfully treated
with theophylline, with their infusion rate adjusted to
a predicted STC using the calculated theophylline
clearance approximated from a single STC obtained
24 hours after the start of the theophylline infusion.
Obtaining an STC prior to 24 hours of a continuous
theophylline infusion is recommended in patients
exhibiting signs or symptoms of theophylline toxicity
or in patients who are not responding or have not
received an initial loading dose of theophylline.
Patients with congestive heart failure or hepatic dis-
ease and those receiving drugs known to increase
theophylline half-life may have theophylline dosage
adjustments overestimated by equation 3 unless the
time for the initial STC is appropriately increased.
The theophylline clearance prediction method of
Chiou and co-workers,7 using two appropriately
spaced STCs may be considered for use in these
patient populations and has been evaluated.8
Although dose-dependent kinetics exist for theophyl-
line, evidence for this was not apparent in this study
since the STC changed in direct proportion to the dose
and with predictability.
This study demonstrates the clinical reliability of
using theophylline clearance to individualize the
theophylline infusion rate to achieve a desired STC. It
also shows that a single STC obtained at 24 hours for a
given patient population is the most accurate for the
calculation of theophylline clearance.
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